Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial.
Bruno S, Torrisi R, Costantini M, Baglietto L, Fontana V, Gatteschi B, Melioli G, Nicolo G, Curotto A, Malcangi B, Bruttini GP, Varaldo M, Bruzzi P, Decensi A.
Bruno S, et al. Among authors: curotto a.
J Cell Biochem. 1999 Dec;76(2):311-21. doi: 10.1002/(sici)1097-4644(20000201)76:2<311::aid-jcb14>3.0.co;2-a.
J Cell Biochem. 1999.
PMID: 10618647
Clinical Trial.